A retrospective study to evaluate and compare change in weight after administration of empagliflozin and liraglutide in patients with type 2 diabetes mellitus
Latest Information Update: 14 Apr 2020
At a glance
- Drugs Empagliflozin (Primary) ; Liraglutide (Primary)
- Indications Obesity; Type 2 diabetes mellitus
- Focus Therapeutic Use
- 14 Apr 2020 New trial record
- 10 Apr 2020 Primary endpoint (change in weight after 1 year of empagliflozin as compared with liraglutide) has not been met, as per Results published in the Annals of Pharmacotherapy
- 10 Apr 2020 Results published in the Annals of Pharmacotherapy